US 7,462,360 B2
	Alloferons—immunomodulatory peptides
Soo In Kim, Seoul (Korea, Republic of); Sergey Ivanovich Chernysh, St. Petersburg (Russian Federation); German Petrovich Bekker, Essen (Germany); Natalia Borisovna Makhaldiani, Moscow (Russian Federation); Jules Hoffman, Strasbourg (France); and Philippe Bulet, Vendenhem (France)
Assigned to Entopharm Co., Ltd., Seoul (Korea, Republic of)
Filed on Dec. 23, 2003, as Appl. No. 10/742,864.
Application 10/742864 is a division of application No. 09/748114, filed on Dec. 27, 2000, granted, now 6,692,747.
Claims priority of application No. 99127725 (RU), filed on Dec. 27, 1999.
Prior Publication US 2004/0138137 A1, Jul. 15, 2004
Int. Cl. A61K 38/08 (2006.01); A61K 38/10 (2006.01); A61K 38/16 (2006.01); A61K 38/03 (2006.01)

U.S. Cl. 424—278.1  [514/12; 514/13; 514/14; 514/15]

7 Claims

1. A method of manufacturing a composition having immunomodulatory activity, comprising combining a peptide of up to 30 amino acid residues comprising the amino acid sequence of any one of SEQ ID NOS: 1-4, or a pharmaceutically active salt or ether of the peptide with a conventional additive.